News
SYVC
0.0001
NaN%
--
Weekly Report: what happened at SYVC last week (0908-0912)?
Weekly Report · 09/15 11:37
Weekly Report: what happened at SYVC last week (0901-0905)?
Weekly Report · 09/08 11:39
Weekly Report: what happened at SYVC last week (0825-0829)?
Weekly Report · 09/01 11:33
Weekly Report: what happened at SYVC last week (0818-0822)?
Weekly Report · 08/25 11:46
Weekly Report: what happened at SYVC last week (0811-0815)?
Weekly Report · 08/18 11:37
Weekly Report: what happened at SYVC last week (0804-0808)?
Weekly Report · 08/11 11:46
Weekly Report: what happened at SYVC last week (0728-0801)?
Weekly Report · 08/04 11:48
Weekly Report: what happened at SYVC last week (0721-0725)?
Weekly Report · 07/28 11:49
Weekly Report: what happened at SYVC last week (0714-0718)?
Weekly Report · 07/21 11:37
Weekly Report: what happened at SYVC last week (0707-0711)?
Weekly Report · 07/14 11:49
Weekly Report: what happened at SYVC last week (0630-0704)?
Weekly Report · 07/07 11:39
Weekly Report: what happened at SYVC last week (0623-0627)?
Weekly Report · 06/30 11:46
Weekly Report: what happened at SYVC last week (0616-0620)?
Weekly Report · 06/23 11:37
Weekly Report: what happened at SYVC last week (0609-0613)?
Weekly Report · 06/16 11:46
Weekly Report: what happened at SYVC last week (0602-0606)?
Weekly Report · 06/09 11:47
Weekly Report: what happened at SYVC last week (0526-0530)?
Weekly Report · 06/02 11:57
Weekly Report: what happened at SYVC last week (0519-0523)?
Weekly Report · 05/26 11:56
Weekly Report: what happened at SYVC last week (0512-0516)?
Weekly Report · 05/19 11:45
Weekly Report: what happened at SYVC last week (0505-0509)?
Weekly Report · 05/12 11:45
Weekly Report: what happened at SYVC last week (0428-0502)?
Weekly Report · 05/05 11:48
More
Webull provides a variety of real-time SYVC stock news. You can receive the latest news about Synovics Pharma through multiple platforms. This information may help you make smarter investment decisions.
About SYVC
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.